Fast forward to 3:40 in the video to see John H. Weiland, President, CEO and Director of CR Bard Inc., flee an NBC reporter with questions about the company’s defective IVC filter.
At least 27 deaths have been associated with Bard’s Recovery filter — a spider-shaped apparatus that is inserted into the largest vein in the body — over the course of a decade, according to NBC News. Government data shows approximately 300 other non-fatal problems have also been reported with the Recovery.
Even as death and injury reports were climbing, the company decided not to recall the Recovery. Instead, Bard sold about 34,000 of them for nearly three years before replacing them with a modified version with a new name, G2.
Multi District Litigation
Lawsuits from across the country have been consolidated in MDL 2641 docket in Arizona federal court. Fact discovery is under way. The parties reported that they have scheduled seven depositions and are in the process of scheduling more.
Each year, about a quarter of a million blood clot filters are implanted in patients who can’t tolerate blood thinners, most without incident. Eleven companies sell them in the U.S., but Bard’s Recovery filter stood out early as a risky device.
Bard officials declined NBC News’ requests for interviews but in a statement said all its filters have been “appropriately cleared by [the] FDA based on required and accurate documentation and that when used as instructed they demonstrate “significant benefits to patients.”